The Vitamin D Receptor as a Potential Target for the Treatment of Age-Related Neurodegenerative Diseases Such as Alzheimer’s and Parkinson’s Diseases: A Narrative Review
Cells · 2023
DOI: 10.3390/cells12040660 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Władysław Lasoń und 4 weiteren Autor:innen. Beteiligte Einrichtung: Maj Institute of Pharmacology Polish Academy of Sciences, Department of Experimental Neuroendocrinology, Smętna 12 Str., 31-343 Krakow, Poland. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Parkinson Disease, Alzheimer Disease. Die Arbeit wurde bisher 91-mal zitiert (Crossref) und nennt 202 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: statutory funds of the Maj Institute of Pharmacology, Polish Academy of Sciences, Poland.
Themen: Demenz
Abstract (Originalsprache)
The vitamin D receptor (VDR) belongs to the nuclear receptor superfamily of transcription factors. The VDR is expressed in diverse brain regions and has been implicated in the neuroprotective, antiaging, prosurvival, and anti-inflammatory action of vitamin D. Accordingly, a relationship between vitamin D insufficiency and susceptibility to neurodegenerative diseases has been suggested. However, due to the multitargeted mechanisms of vitamin D and its often overlapping genomic and nongenomic effects, the role of the VDR in brain pathologies remains obscure. In this narrative review, we present progress in deciphering the molecular mechanism of nuclear VDR-mediated vitamin D effects on prosurvival and anti-inflammatory signaling pathway activity within the central nervous system. In line with the concept of the neurovascular unit in pathomechanisms of neurodegenerative diseases, a discussion of the role of the VDR in regulating the immune and vascular brain systems is also included. Next, we discuss the results of preclinical and clinical studies evaluating the significance of vitamin D status and the efficacy of vitamin D supplementation in the treatment of Parkinson’s and Alzheimer’s diseases, emphasizing the possible role of the VDR in these phenomena. Finally, the associations of some VDR polymorphisms with higher risks and severity of these neurodegenerative disorders are briefly summarized.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Maj Institute of Pharmacology Polish Academy of Sciences, Department of Experimental Neuroendocrinology, Smętna 12 Str., 31-343 Krakow, Poland.
ORCID-Profile: Danuta Jantas, Monika Leśkiewicz, Agnieszka Basta-Kaim
Förderung
- statutory funds of the Maj Institute of Pharmacology, Polish Academy of Sciences, Poland
Zitieren
APA
Lasoń, W., Jantas, D., Leśkiewicz, M., Regulska, M., & Basta-Kaim, A. (2023). The Vitamin D Receptor as a Potential Target for the Treatment of Age-Related Neurodegenerative Diseases Such as Alzheimer’s and Parkinson’s Diseases: A Narrative Review. Cells. https://doi.org/10.3390/cells12040660
Vancouver
Lasoń W, Jantas D, Leśkiewicz M, Regulska M, Basta-Kaim A. The Vitamin D Receptor as a Potential Target for the Treatment of Age-Related Neurodegenerative Diseases Such as Alzheimer’s and Parkinson’s Diseases: A Narrative Review. Cells. 2023. doi:10.3390/cells12040660
BibTeX
@article{Laso2023,
author = {Lasoń, Władysław and Jantas, Danuta and Leśkiewicz, Monika and Regulska, Magdalena and Basta-Kaim, Agnieszka},
title = {The Vitamin D Receptor as a Potential Target for the Treatment of Age-Related Neurodegenerative Diseases Such as Alzheimer’s and Parkinson’s Diseases: A Narrative Review},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12040660}
}
EUVIMED